Connection

Carsten Krieg to Lung Neoplasms

Back to Details
This is a "connection" page, showing publications Carsten Krieg has written about Lung Neoplasms.
Carsten Krieg
Connection Strength
0.221
Lung Neoplasms
  1. Circulating neutrophil subsets in advanced lung cancer patients exhibit unique immune signature and relate to prognosis. FASEB J. 2020 03; 34(3):4204-4218.
    View in: PubMed
    Score: 0.092
  2. ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial. Lancet Oncol. 2018 05; 19(5):694-704.
    View in: PubMed
    Score: 0.081
  3. Improved IL-2 immunotherapy by selective stimulation of IL-2 receptors on lymphocytes and endothelial cells. Proc Natl Acad Sci U S A. 2010 Jun 29; 107(26):11906-11.
    View in: PubMed
    Score: 0.047
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.